Samaan, M. C., Thabane, L., Banfield, L., Balakumaran, J., Birk, T., Golemiec, B., . . . Athale, U. (2019, September). Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: A systematic review protocol. BMJ Open.
Chicago Style (17th ed.) CitationSamaan, M Constantine, et al. "Evaluating the Endometabolic and Bone Health Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: A Systematic Review Protocol." BMJ Open Sep. 2019.
MLA (9th ed.) CitationSamaan, M Constantine, et al. "Evaluating the Endometabolic and Bone Health Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: A Systematic Review Protocol." BMJ Open, Sep. 2019.
Warning: These citations may not always be 100% accurate.
